Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
44%
Ph phase_4
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (33.3%)
N/A4 (66.7%)

Trials by Status

active_not_recruiting111%
not_yet_recruiting111%
recruiting111%
unknown333%
completed222%
enrolling_by_invitation111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9